Brezplačna dostava za naročila nad 69.99 € na paketomatih Pošte Slovenije.

Preverjanje stanja naročila

Postanite del skupnosti ljubiteljev knjig z vsega sveta in uživajte v številnih ugodnostih. Ustvarite brezplačen račun

Brezplačna dostava Zásilkovna nad 69.99 €

Zbirna točka GLS 4.49 € Zbirna točka DPD 2.99 € Kurirska služba GLS 5.49 € Kurir DPD 3.49 € Kurirska služba 3.49 € Zbirno mesto 3.49 € Zbirno mesto 3.49 € Dostava preko Pošte Slovenije 3.49 €

Kontakt

Kako nakupovati

Pomoč

Moj račun

▸ Prazna :-(

Brezplačna dostava za naročila nad 69.99 € na paketomatih Pošte Slovenije.

Assessing Genetic Risks

Name: Assessing Genetic Risks
Brand: National Academies Press
SKU: 04577790
Price: 101.78 EUR
Availability: InStock
Author: Committee on Assessing Genetic Risks
ISBN: 9780309086608

Implications for Health and Social Policy

Committee on Assessing Genetic Risks

Institute of Medicine

National Academy of Sciences

Jezik

Angleščina

Knjiga Mehka

Koda Libristo: 04577790

Založba National Academies Press, januar 1994

Raising hopes for disease treatment and prevention, but also the specter of discrimination and "desi... Celoten opis

Koda Libristo: 04577790

246 b

101.78 €

50% možnost Preiskali bomo ves svet Kdaj dobim knjigo?

30 dni za vračilo blaga

Drugi so kupili tudi

Oligopolio televisivo y democracia en Colombia Mario Enrique Pinzón Ortiz

Mehka

24.50 €

Raising hopes for disease treatment and prevention, but also the specter of discrimination and "designer genes," genetic testing is potentially one of the most socially explosive developments of our time. This book presents a current assessment of this rapidly evolving field, offering principles for actions and research and recommendations on key issues in genetic testing and screening. Advantages of early genetic knowledge are balanced with issues associated with such knowledge: availability of treatment, privacy and discrimination, personal decisionmaking, public health objectives, cost, and more. Among the important issues covered are: quality control in genetic testing; appropriate roles for public agencies, private health practitioners, and laboratories; value-neutral education and counseling for persons considering testing; and use of test results in insurance, employment, and other settings.